|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Radiologic-Pathologic Conferences of the University of Texas M. D. Anderson Cancer Center |
1 Division of Diagnostic Imaging, The University of Texas M. D. Anderson Cancer
Center, 1515 Holcombe Blvd., Box 57, Houston, TX 77030.
2 Division of Pathology, The University of Texas M. D. Anderson Cancer Center,
Houston, TX.
3 Division of Surgical Oncology, The University of Texas M. D. Anderson Cancer
Center, Houston, TX.
Received May 5, 2008; accepted after revision July 17, 2008.
Address correspondence to R. B. Iyer
(riyer{at}mdanderson.org).
Keywords: adrenal gland brown fat FDG PET/CT pheochromocytoma
A 62-year-old woman with a history of poorly controlled hypertension and anxiety presented with abdominal pain and a hypertensive crisis. Abdominal imaging revealed a 3.5-cm right adrenal mass. A 24-hour urinary collection revealed markedly elevated catecholamines (particularly norepinephrine, which was 774 µg/24 hr [normal, 15-100 µg/24 hr]), confirming the diagnosis of pheochromocytoma.
Dedicated adrenal CT showed an approximately 3.5-cm enhancing mass in the
right adrenal gland with central low attenuation and significant soft-tissue
stranding in the surrounding fat. Whole-body 18F-FDG PET showed
intense uptake of the mass as well as the surrounding retroperitoneal tissues,
with a maximum standardized uptake value of approximately 20 extending into
the mediastinum (Fig. 1A). The
patient received
- and β-blockers in preparation for surgery.
Repeat abdominal CT was performed and revealed a decrease in the previously
seen retroperitoneal stranding (Figs.
1B and
1C). The patient was taken to
the operating room and underwent a right adrenalectomy. Gross sections
revealed a 3.8-cm well-circumscribed tan-yellow tumor in the adrenal gland.
Microscopically, the tumor cells were arranged in solid or alveolar patterns
and surrounded by a capillary-rich framework
(Fig. 1D). The cytoplasm was
amphophilic with a fine granular texture, and the nuclei were round to ovoid
with a single prominent nucleolus. The surrounding adipose tissue was composed
of multivacuolated and univacuolated cells with increased vascularity. The
final pathologic diagnosis was pheochromocytoma with surrounding brown fat
(Fig. 1D).
|
|
|
|
Brown fat is normally present in fetuses and infants and diminishes in adults to account for only 1% of the total body mass. Brown fat may have a metabolic or a thermoregulatory function. Remnants of brown fat in the adult are usually found in the neck, mediastinum, axilla, retroperitoneum, and abdominal wall [2]. Brown adipose tissue has much more sympathetic noradrenergic innervation than white adipose tissue [3]. Norepinephrine also has a regulatory function in brown fat. Catecholamine stimulation increases the number of brown fat cells, stimulates lipolysis and glucose transport, and uncouples protein-1 expression in brown fat cells, resulting in heat production [3].
Brown fat is frequently an incidental finding on FDG PET that may result in false-positive findings [4]. Careful correlation with coregistered CT images should be performed to exclude any masses in areas of brown fat uptake. After injection of the radiotracer, as patients wait to be imaged, controlled room temperature is important to prevent thermogenesis and increased brown fat stimulation. In patients with adrenergic stimulation due to excess catecholamine production, brown adipose tissue may be more abundant than in normal adults. The localization of FDG in areas of excess brown fat in these patients likely results from increased glucose transport related to norepinephrine excess [3, 5].
When interpreting examinations in patients with pheochromocytoma, the
radiologist should bear in mind that FDG uptake may be increased in these
patients because of the high circulating levels of norepinephrine. The
dramatic FDG uptake in the surrounding retroperitoneal regions may make it
difficult to resolve the pheochromocytoma from the surrounding brown fat with
PET alone; PET/CT fusion is particularly helpful in this regard. In this
patient, after administration of
-adrenergic and β-blockers, the
extent of hypervascularity in the retroperitoneal fat decreased. Although
follow-up PET was not performed, it is postulated that brown fat activity on
FDG PET would also have decreased, as has been shown previously
[5].
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |